Sector | Chemicals | Compare with Sector peers |
Industry | Chemicals | Compare with Industry peers |
Website | http://www.meghmanifinechem.com | |
Market Cap | 4,710.75 Cr. | |
Enterprise Value(EV) | 5,523.06 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 47.01 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 24.12 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 44.63 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 283.43 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.00 | Calculated using Price: 1,133.75 |
Dividend Yield | 0.44 | Period Ending 2023-03 |
No. of Shares Subscribed | 4.16 Cr. | 41,550,158 Shares |
FaceValue | 10 | |
About Epigral Ltd. | ||
The Company is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products. |
1 Day |
|
+0.40% |
1 Week |
|
+7.77% |
1 Month |
|
-10.98% |
3 Month |
|
+16.44% |
6 Month |
|
+14.29% |
1 Year |
|
+32.49% |
2 Year |
|
+15.51% |
5 Year |
|
|
10 Year |
|
3 years | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 21.31 | 42.16 | 39.36 | |
Return on Capital Employed (%) | 15.97 | 29.4 | 32.2 | |
Return on Assets (%) | 6.96 | 14.15 | 15.51 |
Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 684 | 726 | 1,069 | 1,128 | |
Non Curr. Liab. | 376 | 865 | 715 | 728 | |
Curr. Liab. | 389 | 532 | 648 | 792 | |
Minority Int. | |||||
Equity & Liab. | 1,449 | 2,124 | 2,432 | 2,648 | |
Non Curr. Assets | 1,267 | 1,677 | 2,013 | 2,210 | |
Curr. Assets | 181 | 447 | 420 | 439 | |
Misc. Exp. not W/O | |||||
Total Assets | 1,449 | 2,124 | 2,432 | 2,648 |
Particulars | 4 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 829 | 1,551 | 2,188 | 1,967 | |
Other Income | 7 | 8 | 9 | 10 | |
Total Income | 836 | 1,559 | 2,198 | 1,976 | |
Total Expenditure | -567 | -1,041 | -1,499 | -1,486 | |
PBIDT | 269 | 518 | 698 | 490 | |
Interest | -34 | -49 | -67 | -79 | |
Depreciation | -74 | -86 | -109 | -123 | |
Taxation | -60 | -131 | -169 | -92 | |
Exceptional Items | |||||
PAT | 101 | 253 | 353 | 196 | |
Minority Interest | |||||
Share Associate | -1 | ||||
Other Related Items | |||||
Consolidated Net Profit | 101 | 253 | 353 | 195 | |
Adjusted EPS | 24 | 61 | 85 | 47 |
Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 229 | 284 | 626 | |
Cash Fr. Inv. | -197 | -455 | -437 | |
Cash Fr. Finan. | -32 | 195 | -200 | |
Net Change | 1 | 24 | -11 | |
Cash & Cash Eqvt | 1 | 25 | 14 |
Wed, 27 Mar 2024
Trading Window-XBRL EPIGRAL LIMITED has informed the Exchange about Closure of Trading Window |
Wed, 27 Mar 2024
Trading Window Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Sat, 09 Mar 2024
Updates Epigral Limited has informed the Exchange regarding 'Recognition & Registration to In-House R&D Unit of the Company from Department of Scientific and Industrial Research (DSIR)'. |
Wed, 27 Mar 2024 |
Close Within 52 Week High Zone |
Close Entering 52 Week High Zone |
High Decrease in 1 Month |
High Increase in 3 Months |
High Increase in 1 Year |